Scarica l'app Stockscreener
220.25
3.78%
8.03
Pre-mercato:
221.52
1.27
+0.58%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché LH Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$212.22
Aprire:
$215.77
Volume 24 ore:
884.45K
Relative Volume:
1.30
Capitalizzazione di mercato:
$18.91B
Reddito:
$12.71B
Utile/perdita netta:
$435.50M
Rapporto P/E:
42.77
EPS:
5.15
Flusso di cassa netto:
$843.20M
1 W Prestazione:
-2.55%
1M Prestazione:
-5.96%
6M Prestazione:
-0.12%
1 anno Prestazione:
+8.46%
Intervallo 1D:
$214.02
$220.86
Intervallo di 1 settimana:
$209.38
$226.93
Portata 52W:
$191.97
$258.59
Labcorp Holdings Inc Stock (LH) Company Profile
Nome
Labcorp Holdings Inc
Settore
Industria
Telefono
(336) 229-1127
Indirizzo
358 S MAIN ST, BURLINGTON, NC
Confronta LH con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LH
Labcorp Holdings Inc
|
220.25 | 18.91B | 12.71B | 435.50M | 843.20M | 5.15 |
|
TMO
Thermo Fisher Scientific Inc
|
434.73 | 166.47B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
192.07 | 135.88B | 23.88B | 3.90B | 5.30B | 5.28 |
|
IDXX
Idexx Laboratories Inc
|
421.59 | 32.74B | 3.90B | 887.87M | 798.08M | 10.67 |
|
A
Agilent Technologies Inc
|
102.81 | 29.40B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
143.61 | 26.30B | 15.41B | 1.37B | 2.11B | 7.50 |
Labcorp Holdings Inc Stock (LH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-04-02 | Iniziato | Redburn Atlantic | Buy |
| 2025-03-04 | Aggiornamento | Citigroup | Neutral → Buy |
| 2025-01-07 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2024-12-10 | Ripresa | Jefferies | Buy |
| 2024-10-30 | Aggiornamento | HSBC Securities | Hold → Buy |
| 2024-10-01 | Iniziato | Piper Sandler | Neutral |
| 2024-03-25 | Aggiornamento | Argus | Hold → Buy |
| 2024-02-26 | Iniziato | Leerink Partners | Outperform |
| 2024-02-09 | Iniziato | Evercore ISI | In-line |
| 2024-01-03 | Iniziato | Barclays | Equal Weight |
| 2023-09-06 | Iniziato | HSBC Securities | Hold |
| 2022-12-12 | Downgrade | Citigroup | Buy → Neutral |
| 2022-09-19 | Downgrade | Argus | Buy → Hold |
| 2022-08-22 | Ripresa | Morgan Stanley | Overweight |
| 2022-01-28 | Downgrade | Deutsche Bank | Buy → Hold |
| 2021-01-11 | Aggiornamento | Argus | Hold → Buy |
| 2021-01-11 | Downgrade | Wolfe Research | Peer Perform → Underperform |
| 2021-01-08 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2020-07-14 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2020-07-13 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2020-06-02 | Ripresa | Deutsche Bank | Buy |
| 2020-05-15 | Aggiornamento | Mizuho | Neutral → Buy |
| 2020-04-29 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-04-27 | Aggiornamento | Citigroup | Neutral → Buy |
| 2020-04-27 | Aggiornamento | Wolfe Research | Underperform → Peer Perform |
| 2020-01-08 | Iniziato | Wells Fargo | Overweight |
| 2019-07-16 | Aggiornamento | BofA/Merrill | Underperform → Neutral |
| 2019-06-21 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2019-04-02 | Aggiornamento | Jefferies | Hold → Buy |
| 2019-01-17 | Iniziato | UBS | Buy |
| 2019-01-03 | Downgrade | BofA/Merrill | Neutral → Underperform |
| 2018-12-03 | Downgrade | Craig Hallum | Buy → Hold |
| 2018-10-30 | Downgrade | Argus | Buy → Hold |
| 2018-10-25 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2018-10-19 | Ripresa | BofA/Merrill | Buy |
| 2018-06-07 | Aggiornamento | KeyBanc Capital Mkts | Sector Weight → Overweight |
| 2018-05-01 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2018-03-23 | Iniziato | Argus | Buy |
Mostra tutto
Labcorp Holdings Inc Borsa (LH) Ultime notizie
Labcorp Launches Molecular Residual Disease And Liquid Biopsy Solutions - marketscreener.com
Breakthrough Cancer Detection: Labcorp Unveils Ultra-Precise Liquid Biopsy Test with FDA Authorization - Stock Titan
Labcorp (LH) Earnings Expected to Grow: Should You Buy? - Yahoo Finance
The three-year earnings decline is not helping Labcorp Holdings' (NYSE:LH share price, as stock falls another 6.9% in past week - Yahoo Finance
Labcorp acquires ambulatory outreach laboratory business of NMHS - Yahoo Finance
InStride’s Hybrid Clinical Cohorts Fill High-Need Roles in Healthcare - GlobeNewswire Inc.
Drug Abuse Testing Market Forecast Report and Company Analysis 2025-2033 Featuring Danaher, LabCorp, Abbott, Quest Diagnostics, Thermo Fisher Scientific, F. Hoffmann-La Roche, Bio-Rad Labs, Medtronic - Yahoo Finance
Labcorp Holdings: Regaining Credibility - Seeking Alpha
Labcorp Holdings Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Labcorp Q1 Earnings Preview: Diagnostics Arm Likely to Drive Growth - MSN
NOWDiagnostics and Labcorp Collaborate to Expand Access to the Only FDA-Marketing Authorized Over-the-Counter Syphilis Test in the U.S. - marketscreener.com
Labcorp Holdings (NYSE:LH) Has Announced A Dividend Of $0.72 - simplywall.st
Truist Adjusts Labcorp (LH) Price Target Ahead of Q1 Results | L - GuruFocus
Labcorp Declares Quarterly Dividend - Eastern Progress
What You Need to Know Ahead of Labcorp Holdings' Earnings Release - MSN
Truist Securities Lowers Labcorp Price Target to $274 From $285, Maintains Buy Rating - MarketScreener
Baird Adjusts Price Target on Labcorp Holdings to $253 From $292, Keeps Outperform Rating - marketscreener.com
What You Need To Know Ahead Of Labcorp Holdings' Earnings Release - Barchart.com
Labcorp Holdings Inc. (LH) Declares Cash Dividend for Shareholders - GuruFocus
Labcorp (LH) Maintains Quarterly Dividend, Offers 1.25% Yield - GuruFocus
Labcorp Declares Quarterly Dividend | LH Stock News - GuruFocus
Labcorp Holdings Inc. stock outperforms competitors despite losses on the day - MarketWatch
Barclays Adjusts Labcorp Holdings' Price Target to $240 From $260 - MarketScreener
Labcorp Keeps Quarterly Dividend at $0.72 a Share, Payable June 11 to Shareholders of Record as of May 29 - marketscreener.com
Labcorp Holdings Declares Cash Dividend for Shareholders - TipRanks
Full Fed. Circ. Lets Stand Patent Tied To $400M Labcorp Loss - Law360
Evercore ISI Adjusts Price Target on Labcorp Holdings to $260 From $275, Maintains Outperform Rating - MarketScreener
Is it the Right Time to Retain Labcorp Stock in Your Portfolio? - Yahoo Finance
Minimal Residual Disease Testing Market Forecast Report, 2025-2030 - GlobeNewswire Inc.
Labcorp launches blood test to accelerate Alzheimer’s diagnosis - Yahoo Finance
Here's Why Labcorp (LH) is a Strong Growth Stock - Yahoo Finance
Assessing Labcorp Hldgs: Insights From 8 Financial Analysts - Benzinga
Labcorp Launches New Blood Test to Diagnose Alzheimer's Disease - MarketScreener
LH Stock to Gain From Launch of HPV and STI Self-Collection Options - TradingView
Labcorp Launches First-of-its-Kind Immunoassay to Accelerate Path to Diagnosis of Alzheimer's Disease - Financial Times
Redburn Atlantic Initiates Labcorp Holdings at Buy With $276 Price Target - MarketScreener
Esoteric Testing Market Deep Research 2025-2032 | LabCorp, Quest Diagnostics, OPKO Health, Miraca Holdings - openPR.com
Labcorp Launches First-Of-Its-Kind Immunoassay To Accelerate Path To Diagnosis Of Alzheimer's Disease - MarketScreener
Labcorp Holdings (NYSE:LH) Introduces FDA-Approved Self-Collection Tests For HPV And STIs - simplywall.st
Labcorp to Announce First Quarter Financial Results on April 29, 2025 - Eastern Progress
Labcorp to offer HPV and STI self-collection solutions - TipRanks
Game-Changing HPV Testing: Labcorp Rolls Out Private Self-Collection Options Nationwide - Stock Titan
Labcorp Holdings to Announce Q1 2025 Financial Results - TipRanks
Labcorp holdings EVP Amy Summy sells $175,605 in stock By Investing.com - Investing.com Canada
Labcorp Holdings Inc Azioni (LH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
6.78%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):